Top 10 Integrated Utility Companies To Watch In Right Now

The employment picture is looking prettier. But encouraging data released today won�� be enough to trigger a change of policy at the Federal Reserve.

That�� the opinion of Sterne Agee chief economist, Lindsey Piegza, in a note released this morning following reports that initial jobless claims fell 5,000 from 310,000 to 305,000 during the week ending Sept, 21. Piegza writes:

A continued declined in jobless claims suggest at least some improvement in the labor market or at least in the first part of the jobs equation: lower job destruction.� The second part of the equation, job creation, however, remains tepid.� Going forward, at least from the Fed�� point of view, a slower pace of layoffs is not enough to suggest sustainable momentum in the labor market or trigger a change in policy.��

The data, a proxy for layoffs, point to an improving jobs picture. Economists had anticipated a rise in new claims to 330,000. Instead, jobless claims now sit at a level last consistently seen in 2007. That signals rising confidence among employers about the economic recovery.

Top 10 Asian Companies To Invest In Right Now: Allied Nevada Gold Corp(ANV)

Allied Nevada Gold Corp., together with its subsidiaries, engages in the evaluation, acquisition, exploration, and advancement of gold exploration and development projects in the state of Nevada. It principally operates the Hycroft Mine, an open pit heap leach gold and silver mine covering approximately 61,389 acres of mineral rights and is located to the west of Winnemucca, Nevada. The company also involves in the exploration and development of various exploration properties, including Hasbrouck, Mountain View, Three Hills, Wildcat, Maverick Springs, and Pony Creek/Elliot Dome projects. In addition, the company holds exploration rights to approximately 100 other exploration properties in Nevada. Allied Nevada Gold Corp. was incorporated in 2006 and is headquartered in Reno, Nevada.

Advisors' Opinion:

• [By Travis Hoium]

  What: Gold and silver miners are taking it on the chin today. Royal Gold (NASDAQ: RGLD  ) fell as much as 10.4%, Allied Nevada Gold (NYSEMKT: ANV  ) fell up to 11.5%, and Silver Wheaton (NYSE: SLW  ) dropped as much as 11.2%.

Top 10 Integrated Utility Companies To Watch In Right Now: Honeywell International Inc.(HON)

Honeywell International Inc. operates as a diversified technology and manufacturing company worldwide. Its Aerospace segment provides turbine propulsion engines, auxiliary power units, environmental control and electric power systems, engine systems and accessories, avionic systems, aircraft lighting, inertial sensors, control products, space products and subsystems, and landing products for aircraft manufacturers, airlines, business and general aviation, military, space, and airport operations, as well as offers management and technical, logistics, aircraft wheels and brakes and repair, and overhaul services. The company?s Automation and Control Solutions segment provides environmental and combustion controls, and sensing controls; security and life safety products and services; scanning and mobility products; process automation products and solutions; and building solutions and services for homes, buildings, and industrial facilities. Its Specialty Materials segment prov ides resins and chemicals; hydrofluoric acid; fluorocarbons; fluorine specialties; nuclear services; performance chemicals; chemical processing sealants; fibers and composites; specialty films and additives; imaging and electronic chemicals; semiconductor materials and services; catalysts, adsorbents, and specialties; and renewable fuels and chemicals. It offers these products for refining, petrochemical, automotive, healthcare, agricultural, packaging, refrigeration, appliance, housing, semiconductor, wax, and adhesives segments. This segment also provides process technology and equipment for the petroleum refining, and petrochemical and gas processing industries. The company?s Transportation Systems segment provides charge-air systems; thermal systems; filters, spark plugs, electronic components, and car care products; and brake hard parts and other friction materials for passenger cars and commercial vehicles. The company was founded in 1920 and is headquartered in Morris Township, New Jersey.

Advisors' Opinion:

• [By Rich Smith]

  Honeywell's (NYSE: HON  ) earnings report Friday was quickly overshadowed by news reports that one of its devices, an emergency locator transmitter, may be linked to the on-ground fire that broke out in an Ethiopian Airlines-operated Boeing (NYSE: BA  ) 787 at Heathrow Airport last week.

• [By MONEYMORNING.COM]

  The HomeKit app lets makers of "smart" appliances, such as lights, thermostats, door locks, and so on, connect to Apple's HomeKit app, so all of those things can be controlled from an iPhone. Several big names are already on board, including Koninklijke Philips NV (NYSE ADR: PHG), Kwikset, and Honeywell International Inc. (NYSE: HON).

• [By Laura Brodbeck]

  Friday

  Earnings Expected From: Ericsson (NASDAQ: ERIC), General Electric Company (NYSE: GE), Honeywell International Inc. (NYSE: HON), Johnson Controls, Inc. (NYSE: JCI) Economic Releases Expected:  Dutch consumer confidence, eurozone current account

  Posted-In: Federal ReserveEarnings News Previews Global Pre-Market Outlook Markets Trading Ideas Best of Benzinga

• [By Robert Rapier]

  A number of companies have produced pyrolysis oil for years. Canadian firm Ensyn has been producing pyrolysis oil commercially for 25 years. UOP — a subsidiary of Honeywell (NYSE: HON) and a major supplier of upgrading technology and equipment for oil refiners — has developed technology for upgrading pyrolysis oil into hydrocarbon fuels. In 2008 UOP formed a partnership with Ensyn called Envergent Technologies to commercialize the biomass to pyrolysis oil to drop-in fuels pathway.

Top 10 Integrated Utility Companies To Watch In Right Now: Myriad Genetics Inc (MYGN)

Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the cornerstone technologies of biomarker discovery, high-throughput deoxyribo nucleuc acid (DNA) sequencing, ribo nucleic acid (RNA) expression and multiplex protein analysis. The Company uses this information to guide the development of new molecular diagnostic tests that are designed to assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to ensure optimal treatment (personalized medicine), or assess a patient's risk of disease progression and disease recurrence (prognostic medicine).

As of June 30, 2012, the Company had launched nine commercial molecular diagnostic tests. The Company markets these tests through its own approximate 385-person sales force in the United States. The Company also markets its BRACAnalysis, COLARIS, and COLARIS AP tests through its own European sales force and have entered into marketing collaborations with other organizations in selected Latin American, European and Asian countries. The Company also generates revenue by providing companion diagnostic services to the pharmaceutical, and biotechnology industries and medical research institutions utilizing its multiplexed immunoassay technology.

Molecular Diagnostic Tests

The Company's molecular diagnostic tests are designed to analyze genes, their mutations, expression levels and proteins to assess an individual's risk for developing disease later in life, determine a patient's likelihood of responding to a particular drug, assess a patient's risk of disease progression and disease recurrence and measure a patient's exposure to drug therapy to ensu! re optimal dosing and reduced drug toxicity. The Company's BRACAnalysis test is a analysis of the BRCA1 and BRCA2 genes for assessing a woman's risk of developing hereditary breast and ovarian cancer. BRACAnalysis accounted for 81.7% of the Company's total revenue during the fiscal year ended June 30, 2012. Its The Company's COLARIS test is an analysis of the MLH1, MSH2, MSH6 and PMS2 genes for assessing a person's risk of developing colorectal cancer or uterine cancer.

The Company's COLARIS AP test detects mutations in the APC and MYH genes, which cause a colon polyp-forming syndrome known as Familial Adenomatous Polyposis (FAP), a more common variation of the syndrome known as attenuated FAP, and the MYH-associated polyposis signature (MAP). The Company's MELARIS test analyzes mutations in the p16 gene to determine genetic susceptibility to malignant melanoma. The Company's OnDose test is a nanoparticle immunoassay that is designed to assist oncologists in optimizing 5-FU (fluorouracil) anti-cancer drug therapy in colon cancer patients on an individualized basis. The Company's PANEXIA test is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. The Company's PREZEON test is an immunohistochemistry test that analyzes the PTEN gene and assesses loss of PTEN function in many cancer types.

The Company's Prolaris test is a 46-gene molecular diagnostic assay that assesses whether a patient is likely to have a slow growing, indolent form of prostate cancer that can be safely monitored through active surveillance, or a more aggressive form of the disease that would warrant aggressive intervention, such as a radical prostatectomy or radiation therapy. The Company's TheraGuide 5-FU test analyzes mutations in the DPYD gene and variations in the TYMS gene to assess patient risk of toxicity to 5-FU (fluorouracil) anti-cancer drug therapy.

Companion Diagnostic Services and Other Revenue

! Through M! yriad RBM Inc., the Company provides biomarker discovery and companion diagnostic services to the pharmaceutical, biotechnology, and medical researches industries utilizing its multiplexed immunoassay technology. The Company's technology enables the Company to screen large sets of clinical samples from both diseased and non-diseased populations against the Company's menu of biomarkers. The Company's companion diagnostic services consist of Multi-Analyte Profile (MAP), Multiplexed Immunoassay Kits and TruCulture.

The Company has compiled a library of over 550 individual human and rodent immunoassays for use in its multi-analyte profile (MAP) testing services. The Company has also developed RodentMAP, a panel for use in pre-clinical animal studies and OncologyMAP, which measures cancer-related proteins to assists researchers accelerate the pace of discovery, validation and translation of cancer biomarkers for early detection, patient stratification and therapeutic monitoring. The Company has developed multiplexed immunoassay kits that enable its customers to leverage its technology services with their in-house capabilities. The Company's internally developed multiplexed immunoassay kits include all of the components necessary for a customer to perform a test on their own Luminex instrument. TruCulture is a simple, self-contained whole blood culture that can be deployed to clinical sites around the world for acquiring cell culture data without specialized facilities or training.

Advisors' Opinion:

• [By Monica Gerson]

  Myriad Genetics (NASDAQ: MYGN) shares fell 13.01% to $21.00 in the pre-market trading. Myriad Genetics expressed concerns over CMS not valuing BRCA 2 gene in 81211 code, CMS 81211 payment rate.

Top 10 Integrated Utility Companies To Watch In Right Now: PTC Therapeutics Inc (PTCT)

PTC Therapeutics, Inc., incorporated on March 31, 1998 , is a biopharmaceutical company focused on the discovery and development of orally administered, small-molecule drugs that target post-transcriptional control processes. The Company�� lead product candidate includes ataluren, which is used for the treatment of patients with genetic disorders that arise from a type of genetic mutation known as a nonsense mutation. Ataluren is in late stage clinical development for the treatment of Duchenne muscular dystrophy caused by nonsense mutations (nmDMD) and cystic fibrosis caused by nonsense mutations (nmCF).

Ataluren is orally administered small-molecule compound that targets nonsense mutations. The Company is engaged in the development of ataluren for the treatment of genetic disorders in, which a nonsense mutation is the cause of the disease. Genetic tests are available for many genetic disorders, including Duchenne muscular dystrophy and cystic fibrosis, to determine if the underlying cause is a nonsense mutation. The EMA has designated ataluren as an orphan medicinal product for the treatment of nmDMD and nmCF. During the year ended December 31, 2012, the Phase III clinical trial completed. The Company�� Ataluren clinical trials in patients with nonsense mutation genetic disorders include Ataluren for nmDMD: Phase 2b clinical trial complete; Confirmatory Phase III clinical trial initiated, and Ataluren for nmCF: Phase III trial completed.

Advisors' Opinion:

• [By WWW.DAILYFINANCE.COM]
  Records fell on Wall Street Friday as another solid report on housing lifted the market for the second day in a row. There's a three-day weekend coming up -- something that often prompts investor caution -- but the gains were broad-based even though volume was fairly light. The VIX, which measures volatility, fell to its lowest level this year. The Dow Jones industrial average (^DJI) gained 63 points, the Nasdaq composite (^IXIC) rose 31, and the Standard & Poor's 500 index (^GPSC) added 8, topping the record high set last week. The Dow Transportation average also raced to an all-time high, lifted by airline stocks. United (UAL) soared more than 4 percent; Delta (DAL) gained more than 1 percent and Southwest (LUV) gained 2 percent. Southwest is at an all-time high, up 79 percent from a year ago. New home sales bounced back with a better than expected 6.4 percent increase last month. Lennar (LEN) and D.R. Horton (DHI) both rose 4 percent. Pulte (PHM), Beazer (BZH) and Hovnanian (HOV) also solid posted gains. Earnings continue to drive retail stocks. Gap (GPS) edged higher even though net fell. Foot Locker (FL) gained 1½ percent after topping expectations. GameStop (GME) rose 4 percent. Its net rose, helped by the rollout last year of new Xbox and PlayStation consoles. Zumiez (ZUMZ) rose 5½ percent on an earnings beat. But Aeropostale (ARO) tumbled 24 percent. Its loss widened and sales declined. The retailer continues to struggle with teen fashion trends. Also on the earnings front, TiVo (TIVO) rose 2 percent as it swung to a profit from a year ago loss. It also reported an increase in the number of subscribers. Hewlett-Packard (HPQ) rose 6 percent on news the company plans to eliminate up to 16,000 additional workers in an effort to cut costs. And several stocks extended big moves from yesterday. Best Buy (BBY) rose more than 3 percent for the second straight day after earnings beat expectations. Isis Pharmaceuticals (ISIS) jumped

Top 10 Integrated Utility Companies To Watch In Right Now: Jamba Inc.(JMBA)

Jamba, Inc., through its subsidiary, Jamba Juice Company, owns and franchises Jamba Juice stores. It operates as a restaurant retailer of specialty beverages and food products, which include fruit smoothies, squeezed juices, hot teas, hot oatmeal made with organic steel cut oats, fruit and veggie smoothies, Fit?n Fruitful smoothies with Weight Burner Boost, Whirl?ns frozen yogurt, breakfast wraps, side salads, sandwiches, California Flatbreads, and various baked goods and snacks. The company also licenses its Jamba brand name to sell consumer packaged goods through retail channels, such as grocery, mass, club, and convenience. As of January 3, 2012, it had 769 Jamba Juice stores, including 307 company-owned and operated stores; 443 franchise-operated stores in the United States; and 19 international franchise stores. The company was founded in 1990 and is headquartered in Emeryville, California.

Advisors' Opinion:

• [By Rick Munarriz]

  In this video, Rick argues that the problem could be the ever-widening McCafe menu. The push for smoothies and premium coffee beverages has been generally applauded by analysts, giving the chain pricier drink options that can help prop up the amount that a typical customer will spend at the restaurant. Fruit smoothies helped define Jamba (NASDAQ: JMBA  ) and provided a spark at Starbucks (NASDAQ: SBUX  ) , but these are companies that specialize in beverages. Having a broad range of menu items at Jamba Juice and Starbucks is fine. It's different at McDonald's where customers call it "fast food" for a reason. If customers are waiting longer and the cacophony of automated smoothie blenders and coffee orders that aren't made just right are hurting the dining experience, McDonald's may want to reconsider the upscale shot.

• [By Brian Pacampara]

  What: Shares of Jamba Juice (NASDAQ: JMBA  ) plummeted 19% today after the fruit smoothie chain slashed its outlook for 2013.

  So what: Jamba shares have rallied nicely over the past year on steadily improving same-store sales, but yesterday's downbeat guidance reignites serious concerns over its ability to grow profitably. While the news wasn't all bad (Jamba also announced that retail giant Target�will be rolling out 1,000 JambaGo locations), management's disappointing outlook for sales, four-wall profit margins, and operating earnings suggests that Jamba's competitive position is rapidly weakening.

• [By Sean Williams]

  Anything but smoothie
  Fruit smoothie and juice maker Jamba (NASDAQ: JMBA  ) recently completed a 1-for-5 reverse split to make its share price more attractive to more risk-averse investors and Wall Street institutions. However, no amount of cosmetic changes is enough to hide the lack of progress at Jamba over the past six years.

• [By Teresa Rivas]

  Jamba (JMBA) was rising 5% in after-hours trading, following the smoothie maker�� second-quarter earnings report.

  The company said it earned 36 cents a share, meeting analysts��expectations. However, revenue of $67.3 million was below the $70.4 million consensus.

  System-wide same-store sales rose 1.7%: That includes a 2.2% comp increase for company-owned stores, while franchise operated locations logged a 1.2% gain.

  Jamba says it plans to develop 60 to 80 stores in the U.S. and oversees for the fiscal year as a whole, as well as add 1,000 JambaGo served locations.

  The stock is up 22% in the past year, keeping pace with the broader market.

Top 10 Integrated Utility Companies To Watch In Right Now: Maxygen Inc.(MAXY)

Maxygen, Inc., a biopharmaceutical company, focuses on developing improved versions of protein drugs in North America and Europe. The company utilizes its MolecularBreeding directed evolution technology platform, along with ancillary technologies, and protein modification expertise to pursue the creation of biosuperior proteins. It engages in the discovery, research, and development of MAXY-G34 product candidates for the treatment of chemotherapy-induced neutropenia. The company was founded in 1996 and is headquartered in Redwood, California.

Advisors' Opinion:

• [By Geoff Gannon]

  1. Steel Excel (SXCL)
  2. FormFactor (FORM)
  3. Imation (IMN)
  4. Tuesday Morning (TUES)
  5. Pacific Biosciences (PACB)
  6. Maxygen (MAXY)
  7. Westell (WSTL)
  8. Volt Information Sciences (VISI)
  9. Yasheng Group (YHGG)

Top 10 Integrated Utility Companies To Watch In Right Now: Scholastic Corporation(SCHL)

Scholastic Corporation, together with its subsidiaries, operates as a children?s publishing, education, and media company primarily in the United States. The company?s Children?s Book Publishing and Distribution segment publishes and distributes children?s books through school-based book clubs and book fairs, ecommerce, and the trade channel in the United States. Its Educational Publishing segment publishes and distributes educational technology products and services, curriculum materials, children?s books and collections, classroom magazines, and print and online reference and non-fiction products for grades pre-K to 12 to schools and libraries in the United States. The company?s Media, Licensing, and Advertising segment creates and produces programming and digital content for various platforms, including television, DVDs, audio, movies, interactive games, applications, and Websites. This segment produces and sells a television library consisting of approximately 50 0 half-hour productions; produces television programming, including the animated series; creates audiovisual adaptations of classic children?s picture books; produces young adult and children?s audio recordings; and creates original and licensed consumer software, including handheld and console products with accessories and mobile applications for grades pre-K to 8. This segment also develops sponsored educational materials and supplementary classroom programs in partnership with government agencies, nonprofit organizations, and business organizations; and operates a direct-to-home catalog business specializing in children?s toys. Its International segment publishes and distributes products and services in Canada, the United Kingdom, Australia, New Zealand, Ireland, India, China, Singapore, and other parts of Asia, as well as includes its export and foreign rights businesses. Scholastic Corporation was founded in 1920 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Mark Lin]

  What implications does this have for Amazon and peers such as Barnes & Noble (NYSE: BKS  ) and Scholastic Corporation (NASDAQ: SCHL  ) ?

• [By Sue Chang]

  Scholastic Corp. (SCHL) �is forecast to report a loss of 37 cents a share in the fiscal third quarter.

• [By Rich Duprey]

  Children's book publisher�Scholastic (NASDAQ: SCHL  ) announced today its fiscal 2014 first-quarter dividend of $0.125 per share on its Class A and common shares, the same rate it's paid for the past six quarters.